Espire Hospi

Why is Espire Hospitality Ltd falling/rising?

As of 01-Sep, Espire Hospitality Ltd's stock price is at Rs 152.70, having risen 2.21% over the last two days with a total return of 4.5%. Despite this short-term gain and increased investor interest, the stock remains below its moving averages, indicating potential long-term challenges.

As of 01-Sep, Espire Hospitality Ltd's stock price is rising, currently at Rs 152.70, reflecting an increase of Rs 3.3 or 2.21%. This upward movement follows a trend where the stock has gained for the last two days, accumulating a total return of 4.5% during this period. Additionally, the stock has outperformed its sector by 3.78% today, indicating a stronger performance relative to its peers.<BR><BR>Investor participation has also increased, with a notable rise in delivery volume by 39.64% compared to the 5-day average, suggesting growing interest among investors. Furthermore, the stock reached an intraday high of Rs 155.95, which is a 4.38% increase from its previous price.<BR><BR>Despite these positive indicators, it is important to note that the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests that while there is a short-term rise, the stock's longer-term performance may still be under pressure. Overall, the combination of recent gains, increased investor participation, and sector outperformance contributes to the current rise in Espire Hospitality Ltd's stock price.

Which are the latest news on Espire Hospi?

Who are in the management team of Espire Hospi?

The management team of Espire Hospi includes Gagan Oberoi (Chairperson), Prithvi Raj Singh (Managing Director), Leela Rani Bisht, Amit Rai (Directors), Sumeer Narain Mathur (CFO & Company Secretary), and independent directors Pramod Bhatnagar, Dileep Kumar, and Amit Kumar Jain.

The management team of Espire Hospi includes the following members:<BR><BR>1. Gagan Oberoi - Chairperson<BR>2. Prithvi Raj Singh - Managing Director<BR>3. Leela Rani Bisht - Director<BR>4. Amit Rai - Director<BR>5. Sumeer Narain Mathur - CFO & Company Secretary<BR>6. Pramod Bhatnagar - Independent Director<BR>7. Dileep Kumar - Independent Director<BR>8. Amit Kumar Jain - Independent Director<BR><BR>If you need more information about their roles or the company, feel free to ask!

What does Espire Hospi do?

Espire Hospitality Ltd operates in real estate services and hotel operations within the Hotels & Resorts industry. As of June 2026, it reported net sales of 37 Cr and a net profit of 3 Cr, with a market cap of INR 234 Cr.

Overview:<BR>Espire Hospitality Ltd is engaged in the business of real estate services and hotel operations, operating within the Hotels & Resorts industry and classified as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in October 1991 and was formerly known as Wellesley Corporation Limited until its name change on January 17, 2022. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 37 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 3 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 234 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 25.00 <BR>Industry P/E: 25 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 2.69 <BR>Return on Equity: 18.24% <BR>Price to Book: 4.47 <BR><BR>Contact Details:<BR>Address: Shop No 1 Country Inn, Mehragaon Bhimtal UTT : 248179 <BR>Tel: 91-011-2618 4535/2618 4411 <BR>Email: investor@wellesleycorp.com <BR>Website: http://www.espirehospitality.com

Who are the peers of the Espire Hospi?

Espire Hospi's peers include Sayaji Hot. Pune, Asian Hotels (E), Graviss Hospital, Country Club Hos, Savera Industrie, HBG Hotels, The Byke Hospi., and Grand Continent. Espire Hospi has below-average management risk and growth, with the lowest 1-year return at -71.69% among its peers.

Peers: The peers of Espire Hospi are Sayaji Hot. Pune, Asian Hotels (E), Graviss Hospital, Country Club Hos, Savera Industrie, HBG Hotels, The Byke Hospi., and Grand Continent.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sayaji Hot. Pune and Savera Industrie, while Average management risk is found at Asian Hotels (E) and Grand Continent. Below Average management risk is noted at Espire Hospi, Graviss Hospital, Country Club Hos, HBG Hotels, and The Byke Hospi. Growth is Excellent at Espire Hospi, Good at Savera Industrie and Grand Continent, and Average at Asian Hotels (E). Below Average growth is seen at Sayaji Hot. Pune, Graviss Hospital, Country Club Hos, HBG Hotels, and The Byke Hospi. Capital Structure is Excellent at Sayaji Hot. Pune and Savera Industrie, Good at Graviss Hospital and Grand Continent, and Below Average at Asian Hotels (E), Espire Hospi, Country Club Hos, HBG Hotels, and The Byke Hospi.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Savera Industrie at 3.35%, while the peer with the lowest is Espire Hospi at -71.69%, indicating a significantly poorer performance compared to its peers. Additionally, HBG Hotels, The Byke Hospi., and Country Club Hos have negative six-month returns.

How big is Espire Hospi?

As of 31st August, Espire Hospitality Ltd has a market capitalization of 234.00 Cr, with Net Sales of 139.90 Cr and a Net Profit of 9.32 Cr reported in the latest four quarters. Shareholder's Funds are 43.51 Cr and Total Assets amount to 181.20 Cr as of March 2025.

As of 31st August, Espire Hospitality Ltd has a market capitalization of 234.00 Cr, classifying it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 139.90 Cr and a Net Profit of 9.32 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 43.51 Cr and Total Assets of 181.20 Cr.

Should I buy, sell or hold Espire Hospitality Ltd?

When is the next results date for Espire Hospitality Ltd?

The next results date for Espire Hospitality Ltd is 14 August 2026.

The next results date for Espire Hospitality Ltd is scheduled for 14 August 2026.

Are Espire Hospitality Ltd latest results good or bad?

Espire Hospitality Ltd's latest Q4 FY26 results show mixed outcomes, with record revenue of ₹42.67 crores but a significant 48.48% drop in net profit to ₹4.22 crores and a decline in operating margins, indicating serious operational challenges and high debt levels. Overall, the results are more concerning than favorable, suggesting caution for investors.

Espire Hospitality Ltd's latest results for Q4 FY26 present a mixed picture, but overall, they lean towards the negative side. While the company achieved its highest-ever quarterly revenue of ₹42.67 crores, this was overshadowed by a significant decline in profitability. The net profit dropped sharply by 48.48% quarter-on-quarter to ₹4.22 crores, and the operating margin fell dramatically from 35.73% to 11.48%. <BR><BR>This decline in profitability despite revenue growth indicates serious operational challenges. The company's reliance on non-operating income, which constituted a large portion of its profit before tax, raises concerns about the sustainability of its reported earnings. Additionally, the high debt burden, reflected in a debt-to-equity ratio averaging 8.60 times, adds further pressure on its financial stability.<BR><BR>In summary, while revenue growth is a positive sign, the substantial drop in net profit and operating margins, coupled with high leverage and dependence on non-core income, suggest that the results are more concerning than favorable. Investors should approach the company with caution given these factors.

Is Espire Hospi overvalued or undervalued?

As of November 20, 2025, Espire Hospi is considered overvalued with a PE ratio of 169.37, significantly higher than its peers, and despite impressive long-term returns, it has recently underperformed compared to the Sensex.

As of 20 November 2025, the valuation grade for Espire Hospi has moved from very expensive to expensive, indicating a slight improvement but still suggesting high valuation concerns. The company is currently considered overvalued based on its elevated financial ratios, including a PE ratio of 169.37, an EV to EBITDA of 28.88, and a PEG ratio of 70.04, which are significantly higher than industry norms.<BR><BR>In comparison to its peers, Espire Hospi's PE ratio far exceeds that of JSW Steel at 46.74 and Tata Steel at 28.92, both of which are rated as fair and attractive, respectively. This stark contrast highlights the overvaluation of Espire Hospi in the current market. Additionally, while the company has shown impressive returns over the past few years, including a staggering 2495.27% over three years, its recent performance has lagged behind the Sensex, with a 1-month return of -22.85% compared to the Sensex's 1.50%.

Is Espire Hospi technically bullish or bearish?

As of November 17, 2025, the market trend is bearish with moderate strength, supported by bearish indicators from the MACD, moving averages, and Bollinger Bands, despite some bullish momentum in the RSI.

As of 17 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm a bearish outlook. The weekly Bollinger Bands also indicate a bearish trend, while the KST is bearish on the weekly timeframe. Although the weekly RSI shows bullish momentum, it is not sufficient to counter the overall bearish indicators. The Dow Theory indicates no trend on the weekly level and mildly bearish on the monthly level, further supporting the bearish stance.

How has been the historical performance of Espire Hospi?

Espire Hospi has shown significant growth from March 2022 to March 2025, with net sales increasing from 1.69 Cr to 119.55 Cr, and profitability improving with profit after tax rising to 8.27 Cr from a loss. The company's total assets and equity reserves also expanded notably during this period.

Answer:<BR>The historical performance of Espire Hospi shows significant growth in net sales and profitability over the years, particularly from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Espire Hospi's net sales have increased dramatically from 1.69 Cr in March 2022 to 119.55 Cr in March 2025, indicating a strong upward trend. Total operating income followed a similar trajectory, reaching 119.55 Cr in March 2025, up from just 1.69 Cr in March 2022. The company has also improved its operating profit, which turned positive in March 2022 and rose to 23.08 Cr by March 2025. Profit before tax also saw a notable increase, moving from a mere 0.03 Cr in March 2022 to 10.81 Cr in March 2025, while profit after tax reached 8.27 Cr in March 2025, compared to a loss of 0.08 Cr in March 2022. The company's total assets grew significantly from 7.29 Cr in March 2022 to 181.20 Cr in March 2025, reflecting a robust expansion. Total liabilities also increased, from 7.29 Cr in March 2022 to 181.20 Cr in March 2025, primarily driven by long-term borrowings which rose to 69.93 Cr. Despite the increase in liabilities, the company's equity capital and reserves improved, with reserves turning positive at 28.58 Cr in March 2025, up from negative values in previous years. Overall, Espire Hospi's financial performance indicates a strong growth trajectory with improving profitability and asset base.

Who are the top shareholders of the Espire Hospi?

The top shareholders of Espire Hospi are primarily the promoters, with Mrs. Sadhana Rai holding 67.01%. Other significant shareholders include Rajesh Kumar Gupta at 6.96%, individual investors with 18.5%, and a foreign institutional investor with 2.08%.

The top shareholders of Espire Hospi include the promoters, with Mrs. Sadhana Rai holding the largest share at 67.01%. There are no pledged promoter holdings. Additionally, Rajesh Kumar Gupta is the highest public shareholder, owning 6.96%. The company also has individual investors holding a combined 18.5%, and there is one foreign institutional investor (FII) that holds 2.08%. Overall, the majority of the shares are held by the promoters.

Has Espire Hospi declared dividend?

No Dividend History Available